Clinical and Translational Science Award. University at Buffalo Clinical and Translational Science Institute. Timothy Murphy (Principal Investigator). NIH. 1/1/2025-12/1/2031.
Rhythm Evaluation for AntiCoagulaTion for Atrial Fibrillation (REACT AF). Anne Curtis (Co-Investigator). NIH. $66,278. 8/1/2023-7/1/2029.
Cardiovascular Risk Reduction for Adults with Food Insecurity Using Structured Incentives (CVD-FIT). Leonard Egede (Co-Investigator). NIH/NIHMHD. 9/1/2024-6/1/2029.
NIMHD Center of Excellence in Investigator Development and Community Engagement. Timothy Murphy (Principal Investigator). NIH. $3,600,000. 7/1/2024-6/1/2029.
Posttranslational modifications of glucocorticoid receptor associated with drug resistance in prostate cancer. Remi Adelaiye-Ogala (Principal Investigator). NCI/NIH. 4/1/2024-5/1/2029.
Cardiovascular Risk Reduction for Adults with Food Insecurity Using Structured Incentives (CVD-FIT). Obinna Ekwunife (Co-Investigator). NIH NIMHD. 9/1/2024-3/1/2029.
Cardiovascular Risk Reduction for Adults with Food Insecurity Using Structured Incentives (CVD-FIT). Jennifer Campbell (Co-Investigator). NIH/NIMHD R01MD018721. 9/1/2024-3/1/2029.
Cardiovascular Risk Reduction for Adults with Food Insecurity Using Structured Incentives (CVD-FIT). Rebekah Walker (Principal Investigator). NIH/NIMHD. 9/1/2024-3/1/2029.
Cardiovascular Risk Reduction for Adults with Food Insecurity Using Structured Incentives (CVD-FIT). Raphael Fraser (Co-Investigator). National Institute on Minority Health and Health Disparities. $3,275,405. 9/1/2024-3/1/2029.
NATiV3: A randomized, double blind, placebo-controled, multicentre, Phase 3 study evaluating long term efficacy and safety of lanifibranor in adult patients with non-cirrhotic non-alcoholic steatohepatitis (NASH) and fibrosis 2 (F2)/fibrosi. Ajay Chaudhuri (Principal Investigator). Inventiva. 5/1/2022-11/1/2028.
A novel continuous glucose monitoring enhanced DPP intervention to prevent type 2 diabetes in adults with prediabetes. Leonard Egede (Co-Investigator). American Diabetes Association. 7/1/2025-7/1/2028.
VA Merit Review, 2IO1BX002659, Preventing and Reversing Interstitial Fibrosis in HFpEF. John Canty, Jr. (Principal Investigator). Department of Veterans Affairs. $1,349,984. 7/1/2020-6/1/2028.
A Novel Continuous Glucose Monitoring Enhanced DPP Intervention to Prevent Type 2 diabetes in Adults with Prediabetes. Raphael Fraser (Principal Investigator). American Diabetes Association. $600,000. 7/1/2025-6/1/2028.
A novel continuous glucose monitoring enhanced DPP intervention to prevent type 2 diabetes in adults with prediabetes. Obinna Ekwunife (Co-Investigator). American Diabetes Association. 7/1/2025-6/1/2028.
A novel continuous glucose monitoring enhanced DPP intervention to prevent type 2 diabetes in adults with prediabetes. Rebekah Walker (Co-Investigator). American Diabetes Association. 7/1/2025-6/1/2028.
The Role of Structural Racism on Disparities in Clinical Outcomes for Diabetes: A Mixed Methods Study. Jennifer Campbell (Co-Investigator). NIH/NIDDK R01 DK135838. 8/1/2023-4/1/2028.
The Role of Structural Racism on Disparities in Clinical Outcomes for Diabetes: A Mixed Methods Study. Leonard Egede (Co-Investigator). NIH/NIDDK. 8/1/2023-4/1/2028.
The Role of Structural Racism on Disparities in Clinical Outcomes for Diabetes: A Mixed Methods Study. Rebekah Walker (Co-Investigator). NIH/NIDDK. 8/1/2023-4/1/2028.
UW Practice-based Suicide Prevention Research Center. Andrew Rogers (Co-Investigator). National Institute on Mental Health. $15,798,321. 2/1/2023-2/1/2028.
Troup Fund/Kaleida Health Foundation Liver Center of Western New York. Andrew Talal (Principal Investigator). Troup Fund/Kaleida Health Foundation Liver Center of Western New York. $3,067,590. 7/1/2018-12/1/2027.
Our translational research programs have resulted in significant advancements in medicine that have led to lifesaving treatments and improved quality of life for people around the world.